Komori
TAUNS Laboratories (197A) · TargetFirst statedLatest Management Plan (2026-07-15): "Advanced"

Expansion into a Comprehensive Diagnostics Company

First written in FY2025. 2 of 3 entries say "Advanced", first in 2026-07-08. Latest entry: 2026-07-15.

3entries
2years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY20252025: 120252026: 22026
Same theme, other companies
Development of the infectious disease POCT and OTC testing businessA theme 2 companies write about · 0 as a headwind · 3 as a tailwind

0 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Moved together

"Expansion into non-infectious disease areas, including chronic diseases, cancer and kidney disease" moved the same way as this thread, in the same document, in 2 of its 3 moves.

22★12
  1. ★This thread
  2. 1Expansion into non-infectious disease areas, including chronic diseases, cancer and kidney disease2×
  3. 2IP and Technology Partnership Investments Toward the 10-Year Business Vision2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for TAUNS Laboratories yet. It last moved in the Management Plan of 2026-07-15: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.